Hillsdale Investment Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Buy |
177,900
+44,700
| +34% | +$1.32M | 0.19% | 158 |
|
|
2025
Q1 | $3.98M | Buy |
133,200
+17,000
| +15% | +$507K | 0.2% | 113 |
|
|
2024
Q4 | $3.33M | Buy |
116,200
+1,100
| +1% | +$31.5K | 0.17% | 173 |
|
|
2024
Q3 | $4.45M | Buy |
115,100
+300
| +0.3% | +$11.6K | 0.34% | 87 |
|
|
2024
Q2 | $3.7M | Buy |
114,800
+3,300
| +3% | +$106K | 0.29% | 128 |
|
|
2024
Q1 | $4.33M | Buy |
111,500
+17,200
| +18% | +$668K | 0.34% | 97 |
|
|
2023
Q4 | $2.9M | Sell |
94,300
-200
| -0.2% | -$6.16K | 0.24% | 162 |
|
|
2023
Q3 | $2.11M | Sell |
94,500
-73,300
| -44% | -$1.64M | 0.19% | 169 |
|
|
2023
Q2 | $3.61M | Sell |
167,800
-6,600
| -4% | -$142K | 0.33% | 127 |
|
|
2023
Q1 | $4.18M | Buy |
+174,400
| New | +$4.18M | 0.36% | 102 |
|